Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FXS6837 in Primary IgA Nephropathy
CTR20254552Phase 2Active
- Sponsor
- Xinghao Pengbo
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of XH-S003 in IgA nephropathy (IgAN), sponsored by Xinghao Pengbo. Started Mar 2026; status: active.
02
Drugs
XH-S003
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on CTR20254552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254552.